Pyridomycin as lead for new antituberculosis agents and synthesis of hypermodified epothilone A analogs
Open access
Author
Date
2014Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-010186540Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH-ZürichSubject
ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; TUBERKULOSTATIKA + ANTITUBERKULOTIKA (PHARMAZIE); KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); ORGANISCHE SYNTHESE (CHEMIE); NATURSTOFFE (ORGANISCHE CHEMIE); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY); TUBERCULOSTATICS + ANTITUBERCULITICS (PHARMACY); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY); ORGANIC SYNTHESIS (CHEMISTRY); NATURAL SUBSTANCES (ORGANIC CHEMISTRY)Organisational unit
02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.03647 - Altmann, Karl-Heinz (emeritus) / Altmann, Karl-Heinz (emeritus)
Notes
Diss., Eidgenössische Technische Hochschule ETH Zürich, Nr. 21961, 2014.More
Show all metadata
ETH Bibliography
yes
Altmetrics